Recent antiarrhythmic drugs.
Jaillon P, Drici M.
Am J Cardiol. 1989 Dec 5;64(20):65J-69J. doi: 10.1016/0002-9149(89)91203-4.
The Frank-Starling mechanism in vertebrate cardiac myocytes.
Shiels HA, White E.
J Exp Biol. 2008 Jul;211(Pt 13):2005-13. doi: 10.1242/jeb.003145.
Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing.
Nánási PP, Szabó Z, Kistamás K, Horváth B, Virág L, Jost N, Bányász T, Almássy J, Varró A.
Prog Biophys Mol Biol. 2020 Nov;157:76-83. doi: 10.1016/j.pbiomolbio.2019.11.001. Epub 2019 Nov 11.
Pacemaker channels and sinus node arrhythmia.
Stieber J, Hofmann F, Ludwig A.
Trends Cardiovasc Med. 2004 Jan;14(1):23-8. doi: 10.1016/j.tcm.2003.09.006.
Echocardiographic Assessment of Cardiac Remodeling According to Obesity Class.
Prajapati R, Qin T, Connelly KA, Merdad A, Chow CM, Leong-Poi H, Ong G.
Am J Cardiol. 2025 Feb 1;236:34-41. doi: 10.1016/j.amjcard.2024.10.035. Epub 2024 Nov 4.
Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.
Woosley RL, Wang T, Stone W, Siddoway L, Thompson K, Duff HJ, Cerskus I, Roden D.
Am Heart J. 1984 May;107(5 Pt 2):1058-65. doi: 10.1016/0002-8703(84)90175-3.
Diseases caused by voltage-gated ion channels.
Fontaine B, Plassart-Schiess E, Nicole S.
Mol Aspects Med. 1997 Dec;18(6):415-63. doi: 10.1016/s0098-2997(97)00050-2.
Electrophysiology and pharmacology of ibutilide.
Naccarelli GV, Lee KS, Gibson JK, VanderLugt J.
Am J Cardiol. 1996 Oct 17;78(8A):12-6. doi: 10.1016/s0002-9149(96)00560-7.
Pirmenol: preclinical pharmacology.
Kaplan HR, Mertz TE, Steffe TJ.
Angiology. 1988 Mar;39(3 Pt 2):281-92.
Effect of cone reconstruction on right ventricular function in patients with Ebstein's anomaly: a meta-analysis.
Li D, Hirata Y, Zhou X, Masuzawa A, Ono M, An Q.
Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):301-306. doi: 10.1093/icvts/ivx312.
